MARÍA PILAR
GARCÍA ALFONSO
Profesora titular de universidad
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (4)
2020
2019
-
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial (Cancer Chemotherapy and Pharmacology, (2019), 83, 6, (1175-1181), 10.1007/s00280-019-03820-7)
Cancer Chemotherapy and Pharmacology
-
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
Cancer Chemotherapy and Pharmacology, Vol. 83, Núm. 6, pp. 1175-1181
2014
-
The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status
Angiogenesis, Vol. 17, Núm. 4, pp. 805-821